Vascular dysfunction in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 6, 2009, Pages 513-520

  Maclay, John D ^a   McAllister, David A ^a   Mills, Nicholas L ^b   Paterson, Finny P ^c   Ludlam, Christopher A ^d   Drost, Ellen M ^a   Newby, David E ^b   MacNee, William ^a,e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Queen's Medical Research Institute   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Arterial stiffness; Cardiovascular diseases; Chronic obstructive; Endothelial function; Pulmonary disease

Indexed keywords

ACETYLCHOLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIGARETTE SMOKE; CORTICOSTEROID; NITROPRUSSIDE SODIUM; TISSUE PLASMINOGEN ACTIVATOR; VERAPAMIL;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD FLOWMETRY; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMORAL ARTERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; SMOKING; TONOMETRY; VASCULAR DISEASE;

AGED; ARTERIES; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; ENDOTHELIUM; FIBRINOLYSIS; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULSATILE FLOW; RISK FACTORS; SMOKING; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR RESISTANCE;

EID: 69949111794     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200903-0414OC     Document Type: Article

References (61)

1. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789. (Pubitemid 46294610)
2. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991;133:795-800.
3. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006;16:63-70.
4. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005;128:2640-2646.
5. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005;128:2068-2075. (Pubitemid 41507542)
6. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711-715. (Pubitemid 26313070)
7. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockcroft JR, Shale DJ. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:1259-1265. (Pubitemid 46905751)
8. Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber O. Determinants of Systemic Vascular Function in Patients with Stable COPD. Am J Respir Crit Care Med 2008;178:1211-1218.
9. Barr RG, Mesia-Vela S, Austin JHM, Basner RC, Keller B, Reeves A, Shimbo D, Stevenson L. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: The Emphysema and Cancer Action Project (EMCAP) study. Am J Respir Crit Care Med 2007;176:1200-1207. (Pubitemid 350256473)
10. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007;12:634-641. (Pubitemid 47414891)
11. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006;113:664-670. (Pubitemid 43754330)
12. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:932-943. (Pubitemid 40627836)
13. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-658. (Pubitemid 34851922)
14. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001;104:191-196. (Pubitemid 32655837)
15. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
16. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield J. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150. (Pubitemid 26017952)
17. Fichtlscherer S. prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient. Circulation 2004;110:1926-1932.
18. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Söderberg S, Boon NA, Donaldson K, Sandstrom T, Blomberg A, et al. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med 2007;357:1075-1082. (Pubitemid 47443212)
19. Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension 2007;49:981-985. (Pubitemid 351664328)
20. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KAA, Boon NA, Webb DJ. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking - a mechanism for arterial thrombosis and myocardial infarction. Circulation 1999;99:1411-1415. (Pubitemid 29140904)
21. Pretorius M, Rosenbaum DA, Lefebvre J, Vaughan DE, Brown NJ. Smoking impairs bradykinin-stimulated t-PA release. Hypertension 2002;39:767-771. (Pubitemid 34252872)
22. Lang N, Gumundsdottir I, Boon N, Ludlam C, Fox K, Newby D. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo. J Am Coll Cardiol 2008;52:33-39. (Pubitemid 351858597)
23. Maclay JD, Mcallister DA, Mills NL, Paterson F, MacNee W. Arterial stiffness in COPD is not related to endothelial function [abstract]. European Respiratory Society Conference 2008:[cited 2009 May] Available from https://www.ersnetsecure.org/public/prg-congres.abstract?ww-i- presentation534198.
24. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
25. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-2605. (Pubitemid 44627304)
26. Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol 2001;52:631-646.
27. Newby DE, Wright RA, Ludlam CA, Fox KA, Boon NA, Webb DJ. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium. Thromb Haemost 1997;78:1242-1248.
28. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003;107:2864-2869. (Pubitemid 36705999)
29. Mills N, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, Breen L, Wilkinson IB, McEniery CM, Donaldson K, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008;63:306-311.
30. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265. (Pubitemid 34084631)
31. Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ, Goodfellow J. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci 2001;101:629-635. (Pubitemid 33135344)
32. Lind L. Arterial compliance influences the measurement of flow-mediated vasodilation, but not acetylcholine-mediated forearm blood flow. The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2007;190:212-215.
33. Witte D, Vandergraaf Y, Grobbee D, Bots M. Measurement of flow-mediated dilatation of the brachial artery is affected by local elastic vessel wall properties in high-risk patients. Atherosclerosis 2005;182:323-330. (Pubitemid 41267201)
34. Wilson DG, Bellamy MF, Ramsey MW, Goodfellow J, Brownlee M, Davies S, Wilson JF, Lewis MJ, Stuart AG. Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. Circulation 1999;99:909-915. (Pubitemid 29094305)
35. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-1241.
36. Monnink SH, van Haelst PL, van Boven AJ, Stroes ES, Tio RA, Plokker TW, Smit AJ, Veeger NJ, Crijns HJ, van Gilst WH. Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests. J Investig Med 2002;50:19-24.
37. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002;40:505-510. (Pubitemid 34833167)
38. Stenborg A, Kalimo H, Viitanen M, Terent A, Lind L. Impaired endothelial function of forearm resistance arteries in CADASIL patients. Stroke 2007;38:2692-2697. (Pubitemid 47494005)
39. Robinson S, Ludlam C, Boon N, Newby D. Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2007;27:1651-1656. (Pubitemid 46986123)
40. Armstrong PW, Baigrie RS, Daly PA, Haq A, Gent M, Roberts RS, Freeman MR, Burns R, Liu P, Morgan CD. Tissue Plasminogen Activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction. J Am Coll Cardiol 1989;13:1469-1476.
41. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902. (Pubitemid 10021186)
42. Rentrop KP, Feit F, Sherman W, Thornton JC. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. Circulation 1989;80:1166-1175.
43. Hrafnkelsdottir T, Wall U, Jern C, Jern S. Impaired capacity for endogenous fibrinolysis in essential hypertension. Lancet 1998;352:1597-1598. (Pubitemid 28515249)
44. Mills NL, Törnqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 2005;112:3930-3936. (Pubitemid 43739491)
45. Vlachopoulos C, Aznaouridis K, Stefanadis C. Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece. Heart 2006;92:1544-1550. (Pubitemid 44629149)
46. McAllister D, Maclay J, Mills N, Mair G, Miller JJ, Anderson D, Newby D, Murchison J, MacNee W. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:1208-1214. (Pubitemid 350256474)
47. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-569. (Pubitemid 46828488)
48. Patel BD, Loo WJ, Tasker AD, Screaton NJ, Burrows NP, Silverman EK, Lomas DA. Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax 2006;61:568-571.
49. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
50. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-1519.
51. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004;24:969-974. (Pubitemid 38620880)
52. Boutouyrie P, Lacolley P, Girerd X, Beck L, Safar M, Laurent S. Sympathetic activation decreases medium-sized arterial compliance in humans. Am J Physiol 1994;267:H1368-H1376. (Pubitemid 2158775)
53. Vedam H, Phillips C, Wang D, Barnes D, Hedner J, Unger G, Grunstein R. Short-term hypoxia reduces arterial stiffness in healthy men. Eur J Appl Physiol 2009;105:19-25.
54. Reboul C. Chronic hypoxia exposure depresses aortic endothelium-dependent vasorelaxation in both sedentary and trained rats: involvement of L-arginine. J Appl Physiol 2005;99:1029-1035. (Pubitemid 41214519)
55. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994;24:471-476. (Pubitemid 24246550)
56. Vanhoutte P. Ageing and endothelial dysfunction. Eur Heart J Suppl 2002;4:A8-A17.
57. Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998;104:552-558. (Pubitemid 28328768)
58. Jensen-Urstad K, Johansson J. Gender difference in age-related changes in vascular function. J Intern Med 2001;250:29-36. (Pubitemid 34208935)
59. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-941. (Pubitemid 24370856)
60. Dransfield M, Washko G, Foreman M, Estepar R, Reilly J, Bailey W. Gender differences in the severity of CT emphysema in COPD. Chest 2007;132:464-470. (Pubitemid 47282377)
61. Martinez F, Curtis J, Sciurba F, Mumford J, Giardino N, Weinmann G, Kazerooni E, Murray S, Criner G, Sin D, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007;176:243-252. (Pubitemid 47195874)